Kidney Diseases  >>  azeliragon (TTP488)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
azeliragon (TTP488) / Cantex Pharma
NCT00287183: 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Completed
2a
110
Canada
PF-04494700 (TTP488), Placebo
Pfizer
Diabetic Nephropathy
08/09
08/09

Download Options